Free Trial

Adherex Technologies (FENC) Stock Price, News & Analysis

Adherex Technologies logo
$8.54 +0.24 (+2.89%)
Closing price 07/2/2025 04:00 PM Eastern
Extended Trading
$8.52 -0.01 (-0.18%)
As of 07/2/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Adherex Technologies Stock (NASDAQ:FENC)

Key Stats

Today's Range
$8.35
$8.61
50-Day Range
$5.63
$8.54
52-Week Range
$3.96
$8.72
Volume
114,106 shs
Average Volume
92,401 shs
Market Capitalization
$235.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.00
Consensus Rating
Buy

Company Overview

Adherex Technologies Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
50th Percentile Overall Score

FENC MarketRank™: 

Adherex Technologies scored higher than 50% of companies evaluated by MarketBeat, and ranked 585th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Adherex Technologies has received a consensus rating of Buy. The company's average rating score is 3.25, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Adherex Technologies has only been the subject of 2 research reports in the past 90 days.

  • Read more about Adherex Technologies' stock forecast and price target.
  • Earnings Growth

    Earnings for Adherex Technologies are expected to decrease in the coming year, from ($0.11) to ($0.15) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Adherex Technologies is -16.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Adherex Technologies is -16.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Adherex Technologies' valuation and earnings.
  • Percentage of Shares Shorted

    5.91% of the float of Adherex Technologies has been sold short.
  • Short Interest Ratio / Days to Cover

    Adherex Technologies has a short interest ratio ("days to cover") of 16.1, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Adherex Technologies has recently decreased by 4.23%, indicating that investor sentiment is improving.
  • Dividend Yield

    Adherex Technologies does not currently pay a dividend.

  • Dividend Growth

    Adherex Technologies does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.91% of the float of Adherex Technologies has been sold short.
  • Short Interest Ratio / Days to Cover

    Adherex Technologies has a short interest ratio ("days to cover") of 16.1, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Adherex Technologies has recently decreased by 4.23%, indicating that investor sentiment is improving.
  • News Sentiment

    Adherex Technologies has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.90 average news sentiment score of Medical companies.
  • MarketBeat Follows

    Only 1 people have added Adherex Technologies to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Adherex Technologies insiders have sold 84.89% more of their company's stock than they have bought. Specifically, they have bought $104,602.00 in company stock and sold $193,400.00 in company stock.

  • Percentage Held by Insiders

    11.76% of the stock of Adherex Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    55.51% of the stock of Adherex Technologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Adherex Technologies' insider trading history.
Receive FENC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Adherex Technologies and its competitors with MarketBeat's FREE daily newsletter.

FENC Stock News Headlines

Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
Fennec Announces Results of Annual Meeting
Fennec - A Sound Case For Long-Term Growth?
See More Headlines

FENC Stock Analysis - Frequently Asked Questions

Adherex Technologies' stock was trading at $6.32 at the start of the year. Since then, FENC shares have increased by 35.1% and is now trading at $8.54.
View the best growth stocks for 2025 here
.

Adherex Technologies Inc. (NASDAQ:FENC) issued its earnings results on Tuesday, May, 13th. The company reported ($0.04) EPS for the quarter, topping analysts' consensus estimates of ($0.12) by $0.08. The business earned $8.51 million during the quarter, compared to analysts' expectations of $8.18 million.
Read the conference call transcript
.

Shares of FENC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Adherex Technologies investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Alphabet (GOOG).

Company Calendar

Last Earnings
5/13/2025
Today
7/02/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
N/A
Current Symbol
NASDAQ:FENC
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$13.00
High Stock Price Target
$13.00
Low Stock Price Target
$13.00
Potential Upside/Downside
+52.2%
Consensus Rating
Buy
Rating Score (0-4)
3.25
Research Coverage
4 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$440 thousand
Pretax Margin
-45.53%

Debt

Sales & Book Value

Annual Sales
$47.54 million
Cash Flow
$0.03 per share
Price / Cash Flow
257.00
Book Value
($0.21) per share
Price / Book
-40.67

Miscellaneous

Free Float
24,354,000
Market Cap
$235.70 million
Optionable
Optionable
Beta
0.39
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:FENC) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners